Thomas E Ichim - 20 Jul 2021 Form 4 Insider Report for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Role
Director
Signature
/s/ Thomas Ichim
Issuer symbol
CELZ
Transactions as of
20 Jul 2021
Net transactions value
-$132,405
Form type
4
Filing time
22 Jul 2021, 20:54:06 UTC
Previous filing
16 Jul 2021
Next filing
30 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELZ Common Stock Sale $42,560 -1,400,000 -16% $0.0304 7,479,522 20 Jul 2021 Direct F1
transaction CELZ Common Stock Sale $46,200 -1,500,000 -20% $0.0308 5,979,522 21 Jul 2021 Direct F2
transaction CELZ Common Stock Sale $43,645 -1,450,000 -24% $0.0301 4,529,522 22 Jul 2021 Direct F3
holding CELZ Common Stock 17,245 20 Jul 2021 By LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
F4 Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.